BTIG Starts ProKidney Corp. (PROK) at Buy, 'Transformational Cell Therapy Approach to Diabetic CKD'
Tweet Send to a Friend
(Updated - July 24, 2023 4:32 PM EDT)
BTIG analyst Justin Zelin initiates coverage on ProKidney Corp. (NASDAQ: PROK) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BTIG analyst Justin Zelin initiates coverage on ProKidney Corp. (NASDAQ: PROK) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
